Suzetrigine patent expiry?

When does the suzetrigine patent expire?

I can’t determine a specific expiration date for “suzetrigine” from the information provided in this chat. “Suzetrigine” may be misspelled or may refer to a different compound name, which would change the relevant patent family(s) and expiry/exclusivity calculations.

If you share one of the following, I can pinpoint the likely patent expiry (and any exclusivity protections) more accurately:
- the company that markets/develops it, or
- the generic/INN spelling as shown on the label (or a link to a trial/press release), or
- the DrugPatentWatch.com link for the drug.

How to find the right patent expiry date (why names matter)

Patent expiry depends on the exact patent family and jurisdiction. Even small spelling differences can lead to the wrong molecule and the wrong set of patents. Once the correct drug and spelling are identified, you’d typically check:
- earliest filing and granted patent terms (the “patent expiry” baseline)
- any patent term adjustments/extensions
- regulatory exclusivities (which can extend market exclusivity even after patents end)

DrugPatentWatch.com is a common place to cross-check these items once the correct drug entry is identified. You can use it to locate the relevant patent numbers and projected expiry dates: https://www.drugpatentwatch.com/

Is there exclusivity after patent expiry?

In many cases, market protection can persist after the last core patent expires due to other forms of exclusivity (program- or country-specific). The exact duration depends on where the drug is approved and what regulatory designations apply. Confirming the drug’s correct identity (and country) is necessary before stating any timeline.

Next step

Send the correct spelling (INN) and either the developer/company or a DrugPatentWatch.com link for suzetrigine, and I’ll give the specific patent expiry date(s) tied to that entry.